vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Aterian, Inc. (ATER). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $15.1M, roughly 1.3× Aterian, Inc.). Apyx Medical Corp runs the higher net margin — -6.8% vs -52.5%, a 45.7% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -13.5%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
APYX vs ATER — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $15.1M |
| Net Profit | $-1.3M | $-7.9M |
| Gross Margin | 62.6% | 56.1% |
| Operating Margin | 0.1% | -51.1% |
| Net Margin | -6.8% | -52.5% |
| Revenue YoY | 34.7% | -38.5% |
| Net Profit YoY | 71.9% | -512.2% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $15.1M | ||
| Q3 25 | $12.9M | $19.0M | ||
| Q2 25 | $11.4M | $19.5M | ||
| Q1 25 | $9.4M | $15.4M | ||
| Q4 24 | $14.2M | $24.6M | ||
| Q3 24 | $11.5M | $26.2M | ||
| Q2 24 | $12.1M | $28.0M | ||
| Q1 24 | $10.2M | $20.2M |
| Q4 25 | $-1.3M | $-7.9M | ||
| Q3 25 | $-2.0M | $-2.3M | ||
| Q2 25 | $-3.8M | $-4.9M | ||
| Q1 25 | $-4.2M | $-3.9M | ||
| Q4 24 | $-4.6M | $-1.3M | ||
| Q3 24 | $-4.7M | $-1.8M | ||
| Q2 24 | $-6.6M | $-3.6M | ||
| Q1 24 | $-7.6M | $-5.2M |
| Q4 25 | 62.6% | 56.1% | ||
| Q3 25 | 64.4% | 56.1% | ||
| Q2 25 | 62.3% | 54.3% | ||
| Q1 25 | 60.1% | 61.4% | ||
| Q4 24 | 63.0% | 63.4% | ||
| Q3 24 | 60.5% | 60.3% | ||
| Q2 24 | 61.7% | 60.4% | ||
| Q1 24 | 58.1% | 65.1% |
| Q4 25 | 0.1% | -51.1% | ||
| Q3 25 | -6.5% | -10.7% | ||
| Q2 25 | -22.6% | -23.1% | ||
| Q1 25 | -32.4% | -24.1% | ||
| Q4 24 | -21.4% | -6.5% | ||
| Q3 24 | -31.6% | -6.6% | ||
| Q2 24 | -45.7% | -11.5% | ||
| Q1 24 | -64.6% | -26.1% |
| Q4 25 | -6.8% | -52.5% | ||
| Q3 25 | -15.4% | -12.0% | ||
| Q2 25 | -33.2% | -25.0% | ||
| Q1 25 | -44.0% | -25.4% | ||
| Q4 24 | -32.5% | -5.3% | ||
| Q3 24 | -40.9% | -6.8% | ||
| Q2 24 | -54.0% | -13.0% | ||
| Q1 24 | -74.0% | -25.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.19 | — | ||
| Q1 24 | $-0.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $4.9M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $15.2M |
| Total Assets | $66.8M | $29.6M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $4.9M | ||
| Q3 25 | $25.1M | $7.6M | ||
| Q2 25 | $29.3M | $10.5M | ||
| Q1 25 | $31.0M | $14.3M | ||
| Q4 24 | $31.7M | $18.0M | ||
| Q3 24 | $28.0M | $16.1M | ||
| Q2 24 | $32.7M | $20.3M | ||
| Q1 24 | $37.3M | $17.5M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $15.2M | ||
| Q3 25 | $5.8M | $22.6M | ||
| Q2 25 | $7.3M | $24.3M | ||
| Q1 25 | $10.5M | $27.0M | ||
| Q4 24 | $14.2M | $30.0M | ||
| Q3 24 | $11.0M | $30.6M | ||
| Q2 24 | $14.7M | $30.9M | ||
| Q1 24 | $20.3M | $33.0M |
| Q4 25 | $66.8M | $29.6M | ||
| Q3 25 | $57.4M | $40.1M | ||
| Q2 25 | $58.2M | $45.4M | ||
| Q1 25 | $60.2M | $49.8M | ||
| Q4 24 | $64.8M | $49.5M | ||
| Q3 24 | $60.7M | $52.1M | ||
| Q2 24 | $65.4M | $59.9M | ||
| Q1 24 | $70.7M | $55.7M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-1.0M |
| Free Cash FlowOCF − Capex | $-2.8M | $-1.0M |
| FCF MarginFCF / Revenue | -14.6% | -6.9% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-1.0M | ||
| Q3 25 | $-3.5M | $-1.6M | ||
| Q2 25 | $-1.2M | $-4.4M | ||
| Q1 25 | $-702.0K | $-3.9M | ||
| Q4 24 | $-2.9M | $-9.0K | ||
| Q3 24 | $-4.4M | $-722.0K | ||
| Q2 24 | $-4.3M | $2.9M | ||
| Q1 24 | $-6.3M | $-6.0K |
| Q4 25 | $-2.8M | $-1.0M | ||
| Q3 25 | $-4.1M | $-1.6M | ||
| Q2 25 | $-1.5M | $-4.4M | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | $2.9M | ||
| Q1 24 | $-6.4M | $-42.0K |
| Q4 25 | -14.6% | -6.9% | ||
| Q3 25 | -31.5% | -8.4% | ||
| Q2 25 | -13.2% | -22.7% | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | 10.3% | ||
| Q1 24 | -62.2% | -0.2% |
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 4.0% | 0.2% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 1.7% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 0.3% | 0.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
